Pfizer Inc Chief Executive Officer Albert Bourla has sold stake worth $5.56 million, according to a regulatory filing that showed the sale was made on Monday, the same day the drugmaker reported positive data on its experimental COVID-19 vaccine.
|
|
Scooped by
Institut sur la gouvernance (IGOPP)
November 11, 2020 11:02 AM
|
Your new post is loading...